Low level bacterial endotoxin activates two distinct signaling pathways in human peripheral blood mononuclear cells

Journal of Inflammation

Volumn 8, Issue , 2011, Pages

  Blomkalns, Andra L ^a   Stoll, Lynn L ^b   Shaheen, Wassim ^b   Romig Martin, Sara A ^b   Dickson, Eric W ^c   Weintraub, Neal L ^a   Denning, Gerene M ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; ENDOTOXIN; INTERLEUKIN 8; LIPID BINDING PROTEIN; MEVINOLIN; SUPEROXIDE; TOLL LIKE RECEPTOR 4;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME SYNTHESIS; ESCHERICHIA COLI; HUMAN; HUMAN CELL; INFLAMMATION; INTRACELLULAR SIGNALING; PERIPHERAL BLOOD MONONUCLEAR CELL; RESPIRATORY BURST; SIGNAL TRANSDUCTION;

BACTERIA (MICROORGANISMS);

EID: 79951951856     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-8-4     Document Type: Article

References (61)

1. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. S Kiechl G Egger M Mayr CJ Wiedermann E Bonora F Oberhollenzer M Muggeo Q Xu G Wick W Poewe J Willeit, Circulation 2001 103 1064 1070 11222467 (Pubitemid 32200178)
2. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. J Niebauer HD Volk M Kemp M Dominguez RR Schumann M Rauchhaus PA Poole-Wilson AJ Coats SD Anker, Lancet 1999 353 1838 1842 10.1016/S0140-6736(98) 09286-1 10359409 (Pubitemid 29251016)
3. Regulation of endotoxin-induced proinflammatory activation in human coronary artery cells: expression of functional membrane-bound CD14 by human coronary artery smooth muscle cells. LL Stoll GM Denning WG Li JB Rice AL Harrelson SA Romig ST Gunnlaugsson FJ Miller Jr NL Weintraub, J Immunol 2004 173 1336 1343 15240728 (Pubitemid 38924313)
4. LPS-binding proteins and receptors. MJ Fenton DT Golenbock, J Leukoc Biol 1998 64 25 32 9665271 (Pubitemid 28304670)
5. Isolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations. TL Gioannini A Teghanemt D Zhang NP Coussens W Dockstader S Ramaswamy JP Weiss, Proc Natl Acad Sci USA 2004 101 4186 4191 10.1073/pnas.0306906101 15010525 (Pubitemid 38405904)
6. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. E Lien TK Means H Heine A Yoshimura S Kusumoto K Fukase MJ Fenton M Oikawa N Qureshi B Monks, et al. J Clin Invest 2000 105 497 504 10.1172/JCI8541 10683379 (Pubitemid 30127250)
7. Important aspects of Toll-like receptors, ligands and their signaling pathways. ZL Chang, Inflamm Res 2010 59 791 808 10.1007/s00011-010-0208-2 20593217
8. A CD14-independent LPS receptor cluster. K Triantafilou M Triantafilou RL Dedrick, Nat Immunol 2001 2 338 345 10.1038/86342 11276205 (Pubitemid 33706345)
9. Lipopolysaccharide regulates macrophage fluid phase pinocytosis via CD14-dependent and CD14-independent pathways. MP Peppelenbosch M DeSmedt T ten Hove SJ van Deventer J Grooten, Blood 1999 93 4011 4018 10339511 (Pubitemid 29249851)
10. Evaluation of CD14 in host defence. P Antal-Szalmas, Eur J Clin Invest 2000 30 167 179 10.1046/j.1365-2362.2000.00610.x 10651843 (Pubitemid 30079576)
11. IRAK-1 Contributes to Lipopolysaccharide-induced Reactive Oxygen Species Generation in Macrophages by Inducing NOX-1 Transcription and Rac1 Activation and Suppressing the Expression of Antioxidative Enzymes. U Maitra N Singh L Gan L Ringwood L Li, Journal of Biological Chemistry 2009 284 35403 35411 10.1074/jbc.M109.059501 19850916
12. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. A Boyum, Scand J Clin Lab Invest Suppl 1968 97 77 89 4179068
13. Pseudomonas pyocyanine alters calcium signaling in human airway epithelial cells. GM Denning MA Railsback GT Rasmussen CD Cox BE Britigan, Am J Physiol 1998 274 893 900 9609727
14. Phagocytic leukocyte oxygenation activities and chemiluminescence: a kinetic approach to analysis. RC Allen, Methods Enzymol 1986 133 449 493 full-text 3821549
15. Lipopolysaccharide recognition, CD14, and lipopolysaccharide receptors. RR Ingalls H Heine E Lien A Yoshimura D Golenbock, Infect Dis Clin North Am 1999 13 341 353, vii 10.1016/S0891-5520(05)70078-7 10340170 (Pubitemid 29248748)
16. Structural biology of the LPS recognition. R Jerala, Int J Med Microbiol 2007 297 353 363 10.1016/j.ijmm.2007.04.001 17481951 (Pubitemid 47188054)
17. Catalytic properties of lipopolysaccharide (LPS) binding protein. Transfer of LPS to soluble CD14. B Yu SD Wright, J Biol Chem 1996 271 4100 4105 10.1074/jbc.271.8.4100 8626747
18. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. E Hailman HS Lichenstein MM Wurfel DS Miller DA Johnson M Kelley LA Busse MM Zukowski SD Wright, J Exp Med 1994 179 269 277 10.1084/jem.179.1.269 7505800 (Pubitemid 24012992)
19. Lipopolysaccharide toxicity-regulating proteins in bacteremia. AH Froon MA Dentener JW Greve G Ramsay WA Buurman, J Infect Dis 1995 171 1250 1257 7538550
20. Dual role of lipopolysaccharide (LPS)-binding protein in neutralization of LPS and enhancement of LPS-induced activation of mononuclear cells. T Gutsmann M Muller SF Carroll RC MacKenzie A Wiese U Seydel, Infect Immun 2001 69 6942 6950 10.1128/IAI.69.11.6942-6950.2001 11598069 (Pubitemid 32995454)
21. An essential role for albumin in the interaction of endotoxin with lipopolysaccharide-binding protein and sCD14 and resultant cell activation. TL Gioannini D Zhang A Teghanemt JP Weiss, J Biol Chem 2002 277 47818 47825 10.1074/jbc.M206404200 12372833 (Pubitemid 36159308)
22. Statins as potent antiinflammatory drugs. DJ Lefer, Circulation 2002 106 2041 2042 10.1161/01.CIR.0000033635.42612.88 12379569 (Pubitemid 35192806)
23. Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering. CP Sparrow CA Burton M Hernandez S Mundt H Hassing S Patel R Rosa A Hermanowski-Vosatka PR Wang D Zhang, et al. Arterioscler Thromb Vasc Biol 2001 21 115 121 11145942 (Pubitemid 32061935)
24. Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: reduction of MRNA levels for interleukin-1beta, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor alpha (PPARalpha) in primary endothelial cells. I Inoue S Goto K Mizotani T Awata T Mastunaga S Kawai T Nakajima S Hokari T Komoda S Katayama, Life Sci 2000 67 863 876 10.1016/S0024-3205(00)00680-9 10946846 (Pubitemid 30491080)
25. Toll-like receptor 4 modulation as a strategy to treat sepsis. X Wittebole D Castanares-Zapatero PF Laterre, Mediators Inflamm 2010 2010 568396 10.1155/2010/568396 20396414
26. Antioxidant effects of statins. LL Stoll ML McCormick GM Denning NL Weintraub, Drugs Today (Barc) 2004 40 975 990 10.1358/dot.2004.40.12.872573 15645009
27. Low-level endotoxin induces potent inflammatory activation of human blood vessels: inhibition by statins. JB Rice LL Stoll WG Li GM Denning J Weydert E Charipar WE Richenbacher FJ Miller Jr NL Weintraub, Arterioscler Thromb Vasc Biol 2003 23 1576 1582 10.1161/01.ATV.0000081741.38087.F9 12816876 (Pubitemid 37108200)
28. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. JC Chow DW Young DT Golenbock WJ Christ F Gusovsky, J Biol Chem 1999 274 10689 10692 10.1074/jbc.274.16.10689 10196138
29. Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. E Faure O Equils PA Sieling L Thomas FX Zhang CJ Kirschning N Polentarutti M Muzio M Arditi, J Biol Chem 2000 275 11058 11063 10.1074/jbc.275.15.11058 10753909 (Pubitemid 30212746)
30. Mouse toll-like receptor 4.MD-2 complex mediates lipopolysaccharide- mimetic signal transduction by Taxol. K Kawasaki S Akashi R Shimazu T Yoshida K Miyake M Nishijima, J Biol Chem 2000 275 2251 2254 10.1074/jbc.275.4.2251 10644670 (Pubitemid 30081977)
31. The biology of Toll-like receptors. TK Means DT Golenbock MJ Fenton, Cytokine Growth Factor Rev 2000 11 219 232 10.1016/S1359-6101(00)00006-X 10817965 (Pubitemid 30337461)
32. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. R Shimazu S Akashi H Ogata Y Nagai K Fukudome K Miyake M Kimoto, J Exp Med 1999 189 1777 1782 10.1084/jem.189.11.1777 10359581 (Pubitemid 29272694)
33. Genetic deficiency of NADPH oxidase does not diminish, but rather enhances, LPS-induced acute inflammatory responses in vivo. WJ Zhang H Wei B Frei, Free Radic Biol Med 2009 46 791 798 10.1016/j.freeradbiomed.2008.12.003 19124074
34. Targeted deletion of the lipopolysaccharide (LPS)-binding protein gene leads to profound suppression of LPS responses ex vivo, whereas in vivo responses remain intact. MM Wurfel BG Monks RR Ingalls RL Dedrick R Delude D Zhou N Lamping RR Schumann R Thieringer MJ Fenton, et al. J Exp Med 1997 186 2051 2056 10.1084/jem.186.12.2051 9396775 (Pubitemid 28013690)
35. LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria. N Lamping R Dettmer NW Schroder D Pfeil W Hallatschek R Burger RR Schumann, J Clin Invest 1998 101 2065 2071 10.1172/JCI2338 9593762 (Pubitemid 28244090)
36. Native high-density lipoprotein augments monocyte responses to lipopolysaccharide (LPS) by suppressing the inhibitory activity of LPS-binding protein. PA Thompson RL Kitchens, J Immunol 2006 177 4880 4887 16982930 (Pubitemid 44469824)
37. Apolipoprotein A-II augments monocyte responses to LPS by suppressing the inhibitory activity of LPS-binding protein. PA Thompson JF Berbee PC Rensen RL Kitchens, Innate Immun 2008 14 365 374 10.1177/1753425908099171 19039060
38. Investigation into the interaction of recombinant human serum albumin with Re-lipopolysaccharide and lipid A. G Jurgens M Muller P Garidel MH Koch H Nakakubo A Blume K Brandenburg, J Endotoxin Res 2002 8 115 126 12028751 (Pubitemid 34546188)
39. High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-alpha production in human monocytes. JH Youn YJ Oh ES Kim JE Choi JS Shin, J Immunol 2008 180 5067 5074 18354232
40. Regulation of interactions of Gram-negative bacterial endotoxins with mammalian cells. TL Gioannini JP Weiss, Immunol Res 2007 39 249 260 10.1007/s12026-007-0069-0 17917069 (Pubitemid 47574891)
41. Acute inflammatory response to endotoxin in mice and humans. S Copeland HS Warren SF Lowry SE Calvano D Remick, Clin Diagn Lab Immunol 2005 12 60 67 15642986
42. CD14-dependent and CD14-independent signaling pathways in murine macrophages from normal and CD14 knockout mice stimulated with lipopolysaccharide or taxol. PY Perera SN Vogel GR Detore A Haziot SM Goyert, J Immunol 1997 158 4422 4429 9127007 (Pubitemid 127483946)
43. CD14-dependent and independent pathways in lipopolysaccharide-induced activation of a murine B-cell line, CH12. S Kimura T Tamamura I Nakagawa T Koga T Fujiwara S Hamada, LX Scand J Immunol 2000 51 392 399 10.1046/j.1365-3083. 2000.00696.x (Pubitemid 30212282)
44. Innate recognition of bacteria: engagement of multiple receptors. M Triantafilou K Brandenburg T Gutsmann U Seydel K Triantafilou, Crit Rev Immunol 2002 22 251 268 12678427 (Pubitemid 36396211)
45. Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. M Triantafilou K Triantafilou, Trends Immunol 2002 23 301 304 10.1016/S1471-4906(02)02233-0 12072369 (Pubitemid 34628773)
46. CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide. RR Ingalls DT Golenbock, J Exp Med 1995 181 1473 1479 10.1084/jem.181.4.1473 7535339
47. The CD11/CD18 integrins: characterization of three novel LPS signaling receptors. RR Ingalls MA Arnaout RL Delude S Flaherty R Savedra Jr DT Golenbock, Prog Clin Biol Res 1998 397 107 117 9575552
48. Beta 2 (CD11/CD18) integrins can serve as signaling partners for other leukocyte receptors. RF Todd HR Petty, J Lab Clin Med 1997 129 492 498 10.1016/S0022-2143(97)90003-2 9142045 (Pubitemid 27285045)
49. Integrins as promiscuous signal transduction devices. HR Petty RF Todd, Immunol Today 1996 17 209 212 10.1016/0167-5699(96)30013-3 8991380 (Pubitemid 26148564)
50. Multiple receptors for endotoxin. SD Wright, Curr Opin Immunol 1991 3 83 90 10.1016/0952-7915(91)90082-C 1711327
51. The importance of the Mac-1, LFA-1 glycoprotein family in monocyte and granulocyte adherence, chemotaxis, and migration into inflammatory sites: insights from an experiment of nature. TA Springer DC Anderson, Ciba Found Symp 1986 118 102 126 3525036
52. Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14. SD Wright RA Ramos A Hermanowski-Vosatka P Rockwell PA Detmers, J Exp Med 1991 173 1281 1286 10.1084/jem.173.5.1281 1708813
53. Monomeric endotoxin:protein complexes are essential for TLR4-dependent cell activation. TL Gioannini A Teghanemt D Zhang EN Levis JP Weiss, J Endotoxin Res 2005 11 117 123 15949139 (Pubitemid 40711488)
54. Toll-like receptor pathway signaling is differently regulated in neutrophils and peripheral mononuclear cells of patients with sepsis, severe sepsis, and septic shock. R Salomao MK Brunialti NE Gomes ME Mendes RS Diaz S Komninakis FR Machado ID da Silva O Rigato, Crit Care Med 2009 37 132 139 10.1097/CCM.0b013e318192fbaf 19050613
55. Lipopolysaccharide-induced expression of cell surface receptors and cell activation of neutrophils and monocytes in whole human blood. NE Gomes MK Brunialti ME Mendes M Freudenberg C Galanos R Salomao, Braz J Med Biol Res 2010 43 853 859 10.1590/S0100-879X2010007500078 20721471
56. Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease. G Pasterkamp JK Van Keulen DP De Kleijn, Eur J Clin Invest 2004 34 328 334 10.1111/j.1365-2362.2004.01338.x 15147329 (Pubitemid 38748072)
57. Toll-like receptor 4 polymorphisms and atherogenesis. S Kiechl E Lorenz M Reindl CJ Wiedermann F Oberhollenzer E Bonora J Willeit DA Schwartz, N Engl J Med 2002 347 185 192 10.1056/NEJMoa012673 12124407 (Pubitemid 34764822)
58. TLR4-NOX4-AP-1 signaling mediates lipopolysaccharide-induced CXCR6 expression in human aortic smooth muscle cells. DN Patel SR Bailey JK Gresham DB Schuchman JH Shelhamer BJ Goldstein BM Foxwell MB Stemerman JK Maranchie AJ Valente, et al. Biochem Biophys Res Commun 2006 347 1113 1120 10.1016/j.bbrc.2006.07.015 16870145 (Pubitemid 44118229)
59. Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B. HS Park HY Jung EY Park J Kim WJ Lee YS Bae, J Immunol 2004 173 3589 3593 15356101 (Pubitemid 39280716)
60. Effects of macrophage colony-stimulating factor on the activities of murine monocytes and peritoneal macrophages in vivo. Y Katsura S Tsuru M Noritake N Shinomiya S Kayashima K Motoyoshi M Rokutanda, Nat Immun 1992 11 167 176 1392404
61. MAC1 mediates LPS-induced production of superoxide by microglia: the role of pattern recognition receptors in dopaminergic neurotoxicity. Z Pei H Pang L Qian S Yang T Wang W Zhang X Wu S Dallas B Wilson JM Reece, et al. Glia 2007 55 1362 1373 10.1002/glia.20545 17654704 (Pubitemid 47328939)